Month: April 2021

Un essai de phase III montre que le nirsevimab protège les nourrissons en bonne santé contre les infections causées par le virus respiratoire syncytial

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Un essai de phase III montre que le nirsevimab protège les nourrissons en bonne santé contre les infections causées par le virus respiratoire syncytial Les infections par le virus respiratoire syncytial (VRS) sont la principale cause d’hospitalisation des nourrissons1–5. L’administration d’une dose de nirsvimab, premier vaccin de sa classe pharmacothérapeutique, est étudiée pour déterminer si elle confère une protection à tous les nourrissons pendant la première saison VRS de leur vie. L’essai de phase III du nirsevimab a atteint son critère d’évaluation principal plus tôt que prévu ; les soumissions réglementaires en vue de son indication pour tous les nourrissons devraient débuter en 2022.PARIS – Le 26 avril 2021 – Les premiers résultats de l’essai MELODY de phase III montrent que le nirsevimab réduit les infections des voies...

IDEX Biometrics 2020 Annual Report on Form 20-F

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Oslo, Norway – 26 April 2021 – IDEX Biometrics ASA, (OSE: IDEX and Nasdaq: IDBA) has filed its 2020 annual report on form 20-F with the U.S. Securities and Exchange Commision (SEC). The report includes audited consolidated financial statements for the year ended 31 December 2020. The 2020 annual report on form 20-F is enclosed in pdf file. The 2020 annual report to Norway, dated 14 April 2021 and the 2020 annual report on form 20-F are available at the company’s web site www.idexbiometrics.com. All SEC filings made available electronically by IDEX Biometris may be obtained from the SEC’s website at www.sec.gov For further information contact: Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 918 00186 Brett L Perry, U.S. Investor RelationsE-mail: bperry@sheltongroup.comTel: + 1 214 272 0070 About IDEX...

Notification of Change in Issuer Rating and Issue Rating

Written by Customer Service on April 26, 2021. Posted in Public Companies.

26 April 2021 G4S plc (“G4S” or the “Company”) Notification of Change in Issuer Rating and Issue Rating G4S notes that following its announcement of 26 February 2021 placing the Company’s ‘BBB-/A-3’ ratings on Credit Watch negative, S&P Global Ratings announced on 22 April 2021, that it had downgraded:G4S plc’s issuer credit rating; and G4S plc’s senior unsecured debt rating (in respect of senior bonds issued by, or guaranteed by, G4S plc),in each case, from BBB- to B. On 8 December 2020 the boards of directors managing Allied Universal Topco LLC (“Allied Universal”) and of G4S announced that they had reached agreement on the terms of a recommended cash offer, to be made by Atlas UK Bidco Limited (“Allied Bidco”), a newly incorporated entity that is indirectly controlled by Allied Universal, to acquire the entire issued and to...

Ergomed expands operations in Japan

Written by Customer Service on April 26, 2021. Posted in Public Companies.

PRESS RELEASE Ergomed expands operations in Japan New legal entity and regional office established in Tokyo responding to client demand Guildford, UK – 26 April 2021: Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, announces that its PrimeVigilance business, a global leader in the provision of pharmacovigilance and medical information services, has established its new legal entity and regional office in Japan and is fully operational from 26 April 2021. The new subsidiary company, trading as PrimeVigilance Japan KK, is based in Tokyo and offers a comprehensive range of pharmacovigilance services, including a dedicated Japanese safety database. Full Japanese language Medical Information services are also provided. This expansion...

Fingerprint Cards AB (publ) publishes annual report for 2020

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Fingerprint Cards AB (publ) today published its annual report for the 2020 fiscal year on the company’s website www.fingerprints.com. The annual report is only published digitally, in the form of a clickable PDF with an interactive table of contents on each page of the document. This information is information Fingerprint Cards AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 08:00 am CEST on April 26, 2021. AttachmentFingerprints 2020_EN_webb

Fingerprint Cards AB (publ) publicerar årsredovisningen för 2020

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Fingerprint Cards AB (publ) publicerade idag årsredovisningen för verksamhetsåret 2020 på sin webbplats www.fingerprints.com. Årsredovisningen publiceras endast digitalt i form av en klickbar PDF med en interaktiv innehållsförteckning på varje sida i dokumentet. Denna information är sådan information som Fingerprint Cards AB är skyldigt att offentliggöra enligt lagen om värdepappersmarknaden. Informationen lämnades för offentliggörande den 26 april 2021 kl. 08:00 CEST. BilagaFingerprints 2020_SVE_webb

Proactive news headlines including Chase Mining Corporation, Red River Resources, Aurumin and Kazia Therapeutics

Written by Customer Service on April 26, 2021. Posted in Mergers And Acquisitions.

Sydney, April 26, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Chase Mining Corporation Ltd (ASX:CML) is trading higher as it welcomes the start of drilling by Red Fox Resources Pty Ltd at the Gipsy Creek Copper-Gold Project in the Cloncurry district of northwest Queensland. Click here Red River Resources Ltd (ASX:RVR) has received encouraging initial results from its first-pass reverse circulation (RC) drilling program at the New Homestead and Don gold prospects, part of its Thalanga Operations in northern Queensland. Click here Aurumin Ltd (ASX:AUN) has started reverse circulation (RC) drilling at its 100%-owned Mt Palmer Project, about 40 kilometres east-southeast of Southern Cross in Western Australia’s Goldfields. Click...

Inspire Medical Systems, Inc. Announces Exclusive Distribution Agreement with Japan Lifeline Co., Ltd to Commercialize Inspire Therapy in Japan

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Reimbursement Review of Inspire Therapy Completed by Japan Ministry of Health Labour and Welfare (MHLW); National Health Insurance Payment Listing Expected in June 2021 Initial Inspire Therapy Implants in Japan Anticipated to Occur in Second Half of 2021 MINNEAPOLIS, Minn., April 26, 2021 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), today announced an exclusive distribution agreement with Japan Lifeline Co., Ltd. (“JLL”), an independent full-service distributor of medical devices, to commercialize Inspire therapy in Japan. The parties entered into this agreement following successful completion of reimbursement review...

Ørsted and Enefit form partnership to deliver large-scale offshore wind in the Baltics

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Ørsted, the global leader in offshore wind, and Enefit, a leading utility and the largest wind energy company in the Baltics, have today signed a memorandum of understanding (MoU) which outlines a vision for becoming the leading offshore wind developer in the Baltic countries. The MoU also sets out a vision to jointly move towards delivering the first offshore wind farm in the Gulf of Riga in the Baltic Sea, before 2030. In September 2020, the Latvian and Estonian governments signed a memorandum of understanding for a joint offshore wind farm, and, subject to a supportive regulatory framework for offshore wind being in place, it’s Ørsted and Enefit’s ambition to deliver this before 2030. Offshore wind offers a clear green path forward for the decarbonisation of the Baltic countries and will be able to deliver large-scale, zero-carbon...

Ørsted og Enefit indgår samarbejde om at levere havvind i stor skala i Baltikum

Written by Customer Service on April 26, 2021. Posted in Public Companies.

Ørsted, der er verdensførende inden for havvind, og Enefit, der er et førende forsyningsselskab og det største vindenergiselskab i Baltikum, har i dag underskrevet en samarbejdserklæring (Memorandum of Understanding), der udlægger en vision om at blive den førende udvikler af havvind i de baltiske lande. Samarbejdserklæringen fastlægger desuden en vision om i fællesskab at arbejde henimod at levere den første havvindmøllepark i Rigabugten i Østersøen inden 2030. De lettiske og estiske regeringer underskrev i september 2020 en samarbejdserklæring om en fælles havvindmøllepark, og såfremt lovgivningsmæssige rammer for havvind falder på plads, er det Ørsted og Enefits ambition at levere på denne erklæring inden 2030. Havvind er en oplagt, grøn vej til at reducere CO2-udledningen i Baltikum og vil kunne producere CO2-neutral elektricitet...

Month: April 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals